SciVision Biotech

SciVision Biotech Gross Margin

The Gross Margin of SciVision Biotech (1786.TW) as of Oct 18, 2026 is 72.00 %. In the previous year, Gross Margin was 74.23 % — a change of -3.00% (lower).

Gross Margin

72.00 %

YoY

-3.00%

Last updated:

Gross Margin of SciVision Biotech is 2025 72.00 % . Gross Margin of SciVision Biotech was 2024 74.23 % . It decreases by -3.00% lower compared to the previous year.

For SciVision Biotech, the gross margin of 72.0% is up versus 67.6% a few years ago.

The SciVision Biotech Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
65.82 TWD
Jan 1, 2019
69.76 TWD
Jan 1, 2020
73.53 TWD
Jan 1, 2021
67.62 TWD
Jan 1, 2022
66.72 TWD
Jan 1, 2023
71.88 TWD
Jan 1, 2024
74.23 TWD
Jan 1, 2025
72.00 TWD
The SciVision Biotech Gross Margin history
YEARGross MarginYoY
72.00 %-3.00%
74.23 %+3.27%
71.88 %+7.73%
66.72 %-1.33%
67.62 %-8.03%
73.53 %+5.40%
69.76 %+5.99%
65.82 %+11.29%
59.14 %+6.19%
55.70 %-5.19%
58.74 %+16.98%
50.22 %+8,602.72%
0.58 %-5.99%
0.61 %-3.26%
0.63 %+81.93%
0.35 %-144.03%
-0.79 %+367.27%
-0.17 %-151.65%
0.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SciVision Biotech Stock analysis

What does SciVision Biotech do? SciVision Biotech Inc, based in Kaohsiung, Taiwan, specializes in the research, development, and production of hyaluronic acid medical products. The company offers subcutaneous fillers for plastic surgery, joint cavity injections for orthopedics, and hyaluronic acid raw materials. It also provides DNA identification, detection, sequencing, and related applications, alongside care products and food manufacturing. SciVision Biotech operates globally across the Americas, Europe, Asia, the Middle East, and Africa. SciVision Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SciVision Biotech stock

Gross Margin of SciVision Biotech is 72.00 % in 2025.

Gross Margin of SciVision Biotech changed from 74.23 % to 72.00 %, representing a -3.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin SciVision Biotech since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's SciVision Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — SciVision Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — SciVision Biotech